C. Mary Beard

Risk of connective-tissue diseases and other disorders after breast implantation.

Background We conducted a population-based, retrospective study to examine the risk of a variety of connective-tissue diseases and other disorders after breast implantation. Methods All women in Olmsted County, Minnesota, who received a breast implant between January 1, 1964, and December 31, 1991 (the case subjects), were studied. For each case subject, two women of the same age (within three years) from the same population who had not received a breast implant and who underwent a medical evaluation within two years of the date of the implantation in the case subject were selected as control subjects. Each womans inpatient and outpatient medical record was reviewed for the occurrence of various connective-tissue diseases, certain other disorders thought to have an autoimmune pathogenesis (e.g., Hashimotos thyroiditis), and cancer other than breast cancer, as well as related symptoms and abnormal results of laboratory tests. The case subjects were categorized according to whether they received implants ...

Complications Leading to Surgery after Breast Implantation

BACKGROUND Local complications that require additional surgical procedures are an important problem for women with breast implants. METHODS We studied 749 women who lived in Olmsted County, Minnesota, and received a first breast implant at the Mayo Clinic between 1964 and 1991. We identified complications that occurred after the initial procedure and after any subsequent implantation. A complication was defined as a surgical procedure performed for any of the following reasons: capsular contracture; rupture of the implant; hematoma or bleeding; infection or seroma of the wound; chronic pain; extrusion, leakage, or sweating of the implant; necrosis of the nipple, areola, or flap; malfunction of the filler port of a tissue expander; and wound dehiscence. RESULTS During follow-up (mean, 7.8 years; range, 0 to 25.8), 208 (27.8 percent) of the women underwent 450 additional implant-related surgical procedures. Ninety-one (20.2 percent) were anticipated, staged procedures or were done because the patient requested a size change or aesthetic improvement, and 359 procedures (79.8 percent) had at least one clinical indication (thus constituting a complication). Complications occurred in 178 (23.8 percent) of the 749 women and involved 274 (18.8 percent) of the 1454 breasts with implants and 321 (18.8 percent) of the 1703 implants. The most frequent problem was capsular contraction (272 cases), followed by rupture of the implant (60), hematoma (55), and wound infection (23). The rate of complications was significantly lower (P<0.001) among women with cosmetic implants (6.5 percent at one year, 12 percent at five years) than among women who underwent implantation after mastectomy for breast cancer (21.8 percent at one year, 34 percent at five years) or prophylactic mastectomy (17.3 percent at one year, 30.4 percent at five years). CONCLUSIONS Women who have had breast implantation frequently experience local complications during the subsequent five years. Complications were significantly less frequent among patients who received implants for cosmetic reasons than among those who received implants after mastectomy for cancer or for cancer prophylaxis.

Epidemiology of adult polycystic kidney disease, Olmsted county, Minnesota: 1935-1980

Between January 1, 1935 and December 31, 1980, adult polycystic kidney disease (APKD) was diagnosed in 40 residents of Olmsted County, Minnesota, resulting in an age- and sex-adjusted annual incidence rate of 1.38/100,000 person-years. In addition, 16 cases were detected at autopsy, increasing the rate to 2.06. It is estimated that 16 additional cases would have been discovered had all deaths come to autopsy, resulting in a rate of 2.75, or approximately twice the incidence rate of cases diagnosed during life. Because of improvements in medical care and diagnostic techniques, APKD has been diagnosed earlier and more frequently in the recent decades. This, along with therapeutic advances, explains the improvement in kidney and patient survival for the patients diagnosed during 1956-1980, as compared to those diagnosed during 1935-1955. Normotension at diagnosis tended to be associated with better kidney and/or patient survival. Cardiovascular disease was the leading cause of death.

The Incidence of Peyronie’s Disease in Rochester, Minnesota, 1950 through 1984

Peyronies disease was diagnosed in 101 male residents of Rochester, Minnesota between 1950 and 1984. Mean patient age at diagnosis was 53 years. The average age-adjusted annual incidence rate of 25.7 and a prevalence rate of 388.6 per 100,000 male population were noted. The steady increase in incidence with time may reflect an increasing tendency to obtain medical help. However, the possibility of a true increase in the incidence rate cannot be ruled out. An effort was made to identify possible risk factors and other disease associations. Rheumatoid arthritis and hypertension were more common among the patients compared to the Rochester population. In contrast, no excess of diabetes mellitus was observed among patients with Peyronies disease.

Cholecystectomy and carcinoma of the colon.

After cholecystectomy the concentration of secondary bile acids in the bile increases. These bile acids have been incriminated in the pathogenesis of carcinoma of the colon. Hence the hypothesis that cholecystectomy predisposes to the development of carcinoma of the colon. To test this hypothesis, 1681 residents of Rochester, Minnesota (460 males and 1221 females), who underwent cholecystectomy during 1950-69, were followed up. Carcinoma of the colon developed in a higher-than-expected number of patients. However, the association was significant only in females (relative risk 1.7; 95% confidence interval 1.1-2.5) and even stronger for right-sided carcinoma of the colon (relative risk 2.1; 95% confidence interval 1.1-3.6). These data support the hypothesis that cholecystectomy may be a predisposing factor in the development of cancer of the colon in women.

Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975

Using the centralized diagnostic data resource for the population of Rochester, Minnesota, we determined the prevalence of medically diagnosed dementia for this community. There were 289 individuals with dementia who were residing in Rochester on January 1, 1975:208 women and 81 men. The overall age-and sex-adjusted rates per 100,000 population were 342 for all dementias and 227 for Alzheimers disease. Prevalence rates increased with age for both sexes. Limiting the denominator to persons ≥,65 years, age-adjusted rates per 100,000 population for men and women were 3,452 and 3,466 (or about 3.5%), respectively, for dementia and 2,007 and 2,675 (2.0 and 2.7%), respectively, for Alzheimers disease.

Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: a case-control study in Rochester, Minnesota, 1980 through 1984.

OBJECTIVE To compare the frequency of use of nonsteroidal anti-inflammatory drugs (NSAIDs) among 302 incident cases of Alzheimers disease (AD) and age- and sex-matched control subjects. DESIGN We undertook a retrospective case-control study, using the resources of the Rochester Epidemiology Project. MATERIAL AND METHODS In ongoing studies of dementia in Rochester, Minnesota, we identified all incident cases of AD with onset between 1980 and 1984. From among all Rochester residents who received care at Mayo Clinic Rochester during those years, we selected one age- (within 3 years) and sex-matched control subject. For this study, exposure to a prescription NSAID was defined as prescribed use for 7 or more days during the 2-year window of time encompassing the year of onset and the year before onset among cases and the corresponding index year and the year prior for control subjects. RESULTS The odds ratio (OR) for exposure, as described, to a prescription NSAID versus no exposure to any NSAID was 0.79 (95% confidence interval [CI], 0.45 to 1.38); the OR was 1.00 (95% CI, 0.52 to 1.92) for women and 0.40 (95% CI, 0.13 to 1.29) for men. Similarly, the overall OR for aspirin exposure versus no NSAID exposure was 0.90 (95% CI, 0.54 to 1.50). CONCLUSION These data are suggestive but not confirmatory of a protective effect of NSAIDs for AD.

The incidence of retinal detachment in Rochester, Minnesota, 1970-1978.

We studied the incidence of rhegmatogenous retinal detachment in Rochester, Minnesota, for the nine-year period from 1970 through 1978. The age-adjusted rate for idiopathic rhegmatogenous retinal detachment was 10.1 per 100,000 population per year (45 cases). Including 12 cases of aphakic retinal detachments, the age-adjusted incidence was 12.9 per 100,000 population per year. Not surprisingly, the incidence rate increased with age in both sexes. By extrapolation from the Rochester rates, the number of cases per year of idiopathic retinal detachment in the United States would be expected to be about 22,000, and the number of both aphakic and idiopathic phakic cases per year would be expected to approach 28,000.

Occurrence of malignant neoplasms in the rochester, minnesota, rheumatoid arthritis cohort

The medical records of all patients with rheumatoid arthritis diagnosed in Rochester, Minnesota, from 1950 to 1975 were examined to determine how many of them had malignant neoplasms. Follow-up averaged more than 14 years with outcome diagnoses complete in 98 percent of cases. All diagnoses of malignant neoplasm in this cohort were identified through the centralized record system based at the Mayo Clinic. Approximately 40 percent of these patients with rheumatoid arthritis were at least 60 years old at diagnosis. For comparison, the expected number of malignancies has been calculated using age-specific and site-specific rates from previous Rochester studies and the number of years of observation from date of diagnosis of rheumatoid arthritis to the date of last examination. Risk ratios have been calculated by dividing the observed number by the expected number of malignancies. Exact 95 percent confidence intervals around the risk ratios were calculated assuming that the observed number of cases has a Poisson distribution and that the expected number is fixed. Those patients with rheumatoid arthritis who had a malignancy before diagnosis have been analyzed separately, because they are at a higher risk. With the exception of multiple myeloma, no association was found between rheumatoid arthritis and subsequent cancer of any site.

Risk of Alzheimer's disease among elderly patients with anemia: Population-based investigations in Olmsted County, Minnesota☆

PURPOSE To evaluate the association, if any, between Alzheimers disease (AD) and anemia among the elderly. METHODS Both case-control and cohort methodologies were used to evaluate this association. The case-control study included all incident cases of AD whose onset occurred during 1980-1984 in Rochester, MN (n = 302). An age- and gender-matched control was selected from among Rochester residents seen for care at Mayo Clinic during the year of onset of the case. All community medical records for cases and controls were reviewed to identify women with hemoglobin levels of < 12 g/dL and men with hemoglobin levels of < 13 g/dL during the year of onset and the prior year for cases and during the index year and year prior for controls. Logistic regression was used to estimate odds ratios (OR). The retrospective cohort study used the 618 residents of Olmsted County, MN, who were > or = 65 years of age and whose anemia, as defined above, was newly recognized in 1986. Standardized incidence ratios (SIR) for AD were estimated by use of the person-years of follow-up in the cohort and the incidence rates of AD for this community. RESULTS In the case-control study, an almost twofold increase in occurrence of AD was associated with anemia (OR, 1.88; 95% CI, 1.17-3.03). For men and women, respectively, the ORs were 1.81 (95% CI, 0.75-4.39) and 1.96 (95% CI, 1.11-3.47). The cohort study showed no overall increase in risk of AD (SIR, 0.98; 95% CI, 0.67-1.37). For men, the SIR was a comparable 1.49 (95% CI, 0.79-2.56), whereas for women the SIR was only 0.79 (95% CI, 0.49-1.23). CONCLUSIONS Although anemia may be a risk factor for AD in the elderly, the mechanism by which anemia contributes to the pathogenesis of AD or to the unmasking of AD symptoms is unknown.